| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/07/1992 | CA2093432A1 Protein from hirudo medicinalis |
| 04/07/1992 | CA1298683C Therapeutic decapeptides |
| 04/07/1992 | CA1298558C Pharmacological/cosmetic preparation containing plant extracts |
| 04/07/1992 | CA1298549C COMPOSITIONS CONTAINING GOLGI .alpha.-MANNOSIDASE II INHIBITORS |
| 04/06/1992 | WO1992005698A1 Regulation of immunoglobulin production by interleukin-9 |
| 04/06/1992 | CA2052809A1 Process for producing secretory immunoglobulin a preparations |
| 04/06/1992 | CA2052808A1 Virus-resistant plants and their production |
| 04/05/1992 | WO1992005748A1 Soluble hirudin conjugates |
| 04/05/1992 | CA2092540A1 Soluble hirudin conjugates |
| 04/04/1992 | WO1992006119A1 Method for treating inflammation using anti-idiotypic antibodies |
| 04/04/1992 | CA2092801A1 Method for treating inflammation using anti-idiotypic antibodies |
| 04/02/1992 | WO1992006218A1 A novel onco-fetal gene, gene product and uses therefor |
| 04/02/1992 | WO1992005447A1 FUNCTIONAL ANTAGONISM BETWEEN PROTO-ONCOPROTEIN c-JUN AND HORMONE RECEPTORS |
| 04/02/1992 | WO1992005446A1 Cloned glutamic acid decarboxylase |
| 04/02/1992 | WO1992005274A1 Framework mutated antibodies and their preparation |
| 04/02/1992 | WO1992005262A1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
| 04/02/1992 | WO1992005256A1 Natural killer stimulatory factor |
| 04/02/1992 | WO1992005255A1 Ovine cytokine genes |
| 04/02/1992 | WO1992005254A1 Novel neurothrophic factor |
| 04/02/1992 | WO1992005199A1 Bmp-5 derivatives |
| 04/02/1992 | WO1992005196A1 Aids therapy and vaccine |
| 04/02/1992 | WO1992005193A1 Plasmodium liver stage antigens |
| 04/02/1992 | WO1992005190A1 Deoxyhypusyl hydroxylase inhibitors |
| 04/02/1992 | WO1992005184A1 A non-mitogenic competitive hgf antagonist |
| 04/02/1992 | WO1992005179A1 Carboxylic acid esters of rapamycin |
| 04/02/1992 | WO1992004913A1 Method for increasing red blood cell production by treatment with activin or activin-related peptides |
| 04/02/1992 | WO1992004910A1 Na-k-atpase inhibiting natriuretic substances |
| 04/02/1992 | DE4103275C1 Agent to prevent hair loss due to seborrhoea - contains peptide(s) from mare's milk, acetate, alpha-tocopherol-acetate of retinol |
| 04/02/1992 | CA2092920A1 Aprotinin analogues |
| 04/02/1992 | CA2092916A1 Onco-fetal gene, gene product and uses therefor |
| 04/02/1992 | CA2090407A1 Functional antagonism between proto-oncoprotein c-jun and hormone receptors |
| 04/02/1992 | CA2069507A1 Aids therapy and vaccine |
| 04/02/1992 | CA2068412A1 Na-k-atpase inhibiting natriuretic substances |
| 04/01/1992 | EP0478366A2 Recombinant hybrid immunoglobulin molecules and method of use |
| 04/01/1992 | EP0478362A2 Fibrinogen receptor antagonists |
| 04/01/1992 | EP0478272A2 Gp98 cell adhesion molecule and integrin complex containing it |
| 04/01/1992 | EP0478146A1 DNA and polypeptide for tumor-associated antigen CO-029 |
| 04/01/1992 | EP0478101A2 Therapeutic use of peptides having thrombospondin-like activity |
| 04/01/1992 | EP0477994A1 Parasite-derived resistance |
| 04/01/1992 | EP0477971A2 Human CNP gene and precursor protein |
| 04/01/1992 | EP0477912A2 Novel N-acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same |
| 04/01/1992 | EP0477885A2 Parathyroid hormone derivatives |
| 04/01/1992 | EP0477833A1 Composition for therapeutic and/or cosmetic use for treatment of circulatory diseases and for aesthetic medicine treatments |
| 04/01/1992 | EP0477791A2 Polypeptide |
| 04/01/1992 | EP0477625A1 Method for preventing or treating anxiety employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| 04/01/1992 | EP0477499A1 Gonadoliberin antagonists |
| 04/01/1992 | EP0477345A1 Respiratory burst suppression factor |
| 04/01/1992 | EP0477307A1 Superantigen induced immune non-responsiveness |
| 04/01/1992 | EP0477269A1 Pharmaceutical compositions and methods of treatment using alzheimer's amyloid polypeptides |
| 04/01/1992 | EP0477201A1 Polymorphism of human platelet membrane glycoprotein iiia and diagnostic application thereof |
| 04/01/1992 | EP0464135A4 Method for reducing side effects of a drug |
| 04/01/1992 | EP0324811B1 Gas inlet for a plurality of various reaction gases in reaction vessels |
| 03/31/1992 | US5101039 Azabicycloamino carboxylic acid intermediates |
| 03/31/1992 | US5101025 Recombinant trichosanthin and coding sequence |
| 03/31/1992 | US5101016 Factor VIII coagulant polypeptides and monoclonal antibodies to them |
| 03/31/1992 | US5100899 Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
| 03/31/1992 | US5100875 Novel peptides having plateler aggregation inhibitory activity |
| 03/31/1992 | US5100874 Collagenase Inhibitors |
| 03/31/1992 | US5100873 Bombesin antagonist, anticancer agents, oligopeptides |
| 03/31/1992 | US5100798 Method for the extraction of a vitamin-k-dependent carboxylase complex and the use thereof |
| 03/31/1992 | US5100788 Method of producing and isolating igg-binding protein a fusion peptides and a vector therefor |
| 03/31/1992 | US5100670 Nonbactericidal, anti-insulinase activity, treatment of diabetes |
| 03/31/1992 | US5100668 Controlled release systems containing heparin and growth factors |
| 03/31/1992 | US5100666 Improved half-life |
| 03/31/1992 | US5100664 Human IL-2 as a vaccine adjuvant |
| 03/31/1992 | US5100661 Method for regulating cellular signal transducing system |
| 03/31/1992 | US5100592 Heated rotary spreaders, two feed streams, melting and coating powders |
| 03/31/1992 | US5100378 Enhancement of target cell localization of lymphoid cells |
| 03/31/1992 | CA1298435C Pentapeptides with cell growth regulatory effects and a process for the preparation thereof |
| 03/31/1992 | CA1298433C Amino acid derivatives |
| 03/31/1992 | CA1298219C Homogeneous immune interferon fragment |
| 03/29/1992 | WO1992006116A1 Hybrid growth factors |
| 03/29/1992 | WO1992005799A1 Method for inhibiting the infectivity of human immunodeficiency virus |
| 03/29/1992 | CA2091253A1 Method for inhibiting the infectivity of human immunodeficiency virus |
| 03/29/1992 | CA2069746A1 Hybrid growth factors |
| 03/29/1992 | CA2051782A1 Aminoesters of rapamycin |
| 03/28/1992 | WO1992006199A2 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides |
| 03/28/1992 | WO1992006115A1 Antagonists of human gamma interferon |
| 03/28/1992 | CA2092546A1 Antibody inductor peptides inhibiting retrovirus of the hiv type and antibodies specific for said peptides |
| 03/28/1992 | CA2092541A1 Antagonists of human gamma interferon |
| 03/28/1992 | CA2052283A1 Recombinant hybrid immunoglobulin molecules and method of use |
| 03/28/1992 | CA2052057A1 Fibrinogen receptor antagonists |
| 03/28/1992 | CA2052043A1 Fibrinogen receptor antagonists |
| 03/27/1992 | CA2052198A1 Therapeutically active peptides and pseudopeptides in the blood clotting cascade, their preparation process and the pharmaceutical compositions containing such |
| 03/26/1992 | WO1992005189A1 Analogues of cyclolinopeptide a and the use thereof |
| 03/26/1992 | WO1992004909A1 Pharmaceutical composition comprising cd4 and a polyanionic anti-hiv agent and use thereof |
| 03/26/1992 | CA2092093A1 Pharmaceutical composition comprising cd4 and a polyanionic anti-hiv agent and use thereof |
| 03/26/1992 | CA2090859A1 Analogues of cyclolinopeptide a and the use thereof |
| 03/25/1992 | EP0477143A2 Pharmaceutical composition having a cicatrising effect |
| 03/25/1992 | EP0476983A1 Vascular endothelial cell growth factor II |
| 03/25/1992 | EP0476953A2 Viral targeted destruction of neoplastic cells |
| 03/25/1992 | EP0476933A1 Neurotrophic peptide derivatives |
| 03/25/1992 | EP0476875A2 Process for the purification and concentration of biologically active materials |
| 03/25/1992 | EP0476515A1 New amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same |
| 03/25/1992 | EP0476233A1 Human MK gene and protein sequence |
| 03/25/1992 | EP0476130A1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 03/25/1992 | EP0476038A1 Chemical products. |
| 03/25/1992 | EP0476022A1 Crystalline r-h-gm-csf and method for the preparation |
| 03/25/1992 | EP0476015A1 Recombinant alzheimer's amyloid protein |
| 03/25/1992 | EP0475972A1 Improved culture of human tumor-infiltrating lymphocytes by combining gas permeable bags and a primary culture container |